Screening and Purification of Nanobodies from E. Coli Culture Supernatants Using the Hemolysin Secretion System
Overview
Microbiology
Affiliations
Background: The hemolysin (Hly) secretion system of E. coli allows the one-step translocation of hemolysin A (HlyA) from the bacterial cytoplasm to the extracellular medium, without a periplasmic intermediate. In this work, we investigate whether the Hly secretion system of E. coli is competent to secrete a repertoire of functional single-domain VHH antibodies (nanobodies, Nbs), facilitating direct screening of VHH libraries and the purification of selected Nb from the extracellular medium.
Results: We employed a phagemid library of VHHs obtained by immunization of a dromedary with three protein antigens from enterohemorrhagic E. coli (EHEC), namely, the extracellular secreted protein A (EspA), the extracellular C-terminal region of Intimin (Int280), and the translocated intimin receptor middle domain (TirM). VHH clones binding each antigen were enriched and amplified by biopanning, and subsequently fused to the C-terminal secretion signal of HlyA to be expressed and secreted in a E. coli strain carrying the Hly export machinery (HlyB, HlyD and TolC). Individual E. coli clones were grown and induced in 96-well microtiter plates, and the supernatants of the producing cultures directly used in ELISA for detection of Nbs binding EspA, Int280 and TirM. A set of Nb sequences specifically binding each of these antigens were identified, indicating that the Hly system is able to secrete a diversity of functional Nbs. We performed thiol alkylation assays demonstrating that Nbs are correctly oxidized upon secretion, forming disulphide bonds between cysteine pairs despite the absence of a periplasmic intermediate. In addition, we show that the secreted Nb-HlyA fusions can be directly purified from the supernatant of E. coli cultures, avoiding cell lysis and in a single affinity chromatography step.
Conclusions: Our data demonstrate the Hly secretion system of E. coli can be used as an expression platform for screening and purification of Nb binders from VHH repertories.
Programmable cancer treatments: Engineering biology approaches for living cures.
Carrera M, Sevko A, Glanville N, Deban L Eng Biol. 2024; 8(2-3):31-40.
PMID: 39473536 PMC: 11514499. DOI: 10.1049/enb2.12032.
Florez V, Marizcurrena J, Lavina M, Azpiroz M Microb Cell Fact. 2024; 23(1):273.
PMID: 39390566 PMC: 11465617. DOI: 10.1186/s12934-024-02552-5.
Engineering a Novel Probiotic Toolkit in for Sensing and Mitigating Gut Inflammatory Diseases.
Weibel N, Curcio M, Schreiber A, Arriaga G, Mausy M, Mehdy J ACS Synth Biol. 2024; 13(8):2376-2390.
PMID: 39115381 PMC: 11334186. DOI: 10.1021/acssynbio.4c00036.
A whole-cell platform for discovering synthetic cell adhesion molecules in bacteria.
Chen P, Chen Y, Chen P, Lin K, Sargsyan K, Hsu C Nat Commun. 2024; 15(1):6568.
PMID: 39095377 PMC: 11297345. DOI: 10.1038/s41467-024-51017-1.
Single domain antibodies from camelids in the treatment of microbial infections.
De Greve H, Fioravanti A Front Immunol. 2024; 15:1334829.
PMID: 38827746 PMC: 11140111. DOI: 10.3389/fimmu.2024.1334829.